IDSA recommends shorter antibiotic courses for adults with cUTIs who show clinical improvement on effective therapy.
Cefepime-taniborbactam was 22% more effective than meropenem, which is a current treatment for complicated urinary tract infections (UTIs) and acute pyelonephritis, according to a study published in ...
inews.co.uk on MSN
Chronic UTI sufferers look forward to first new antibiotic in decades
The first new antibiotic for UTIs in nearly 30 years has been approved by regulators. Gepotidacin, also known as Blujepa, is “first-in-its-class”, which means it uses a unique mechanism to treat UTIs, ...
The girl has suffered from chronic UTIs since the age of 8, with symptoms including painful urination, needing to urinate ...
The U.S. Food and Drug Administration has granted approval to a new antibiotic to treat urinary tract infections in women and adolescent girls. The drug is made by British pharmaceutical company GSK.
Millennial Skin on MSN
Recurring UTIs aren’t normal—here’s what you need to know
Urinary tract infections are among the most common bacterial infections worldwide, but for many people they are not a one-time inconvenience. Recurrent UTIs—typically defined as two or more infections ...
News-Medical.Net on MSN
New database targets hidden causes of chronic urinary tract infections in children
A new database targeting chronic urinary tract infections (UTIs) – a long-overlooked condition that may begin in childhood – ...
Augmentin (amoxicillin/clavulanate potassium) is a prescription drug taken to treat certain types of bacterial infection. The drug comes as an oral liquid suspension ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results